- £515.92m
- £409.62m
- £69.20m
- 36
- 30
- 76
- 42
REG - IP Group PLC - Notice of Results
AnnouncementREG - IP Group PLC - Total Voting Rights
AnnouncementREG - IP Group PLC - Director/PDMR Shareholding
AnnouncementREG - IP Group PLC - Director/PDMR Shareholding
AnnouncementRCS - IP Group PLC - Portfolio company Apollo Therapeutics raises $145m
AnnouncementREG - IP Group PLC - Further re Scrip Dividend
AnnouncementREG - IP Group PLC - Result of AGM
AnnouncementREG - IP Group PLC - AGM Statement
AnnouncementREG - Stock Exch Notice - Admission to Trading - 18/05/2021
AnnouncementRCS - IP Group PLC - Portfolio co Iksuda completes $42m financing round
AnnouncementREG - UK Residential REIT - Intention to Float
AnnouncementREG - IP Group PLC - Director/PDMR Shareholding
AnnouncementRCS - IP Group PLC - Joint venture with China Everbright to launch fund
AnnouncementRCS - IP Group PLC - Portfolio co Pulmocide completes $92m Series C
AnnouncementREG - IP Group PLC - Update on AGM
AnnouncementREG - IP Group PLC - Scrip Dividend Reference Price
AnnouncementREG - IP Group PLC - Additional fair value gain of £20m
AnnouncementREG - Diurnal Group PLC IP Group PLC - Holding(s) in Company
AnnouncementRCS - IP Group PLC - Investor webinars
Announcement